Sientra, Inc. (NASDAQ:SIEN) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research note issued on Thursday.

Several other equities research analysts have also issued reports on SIEN. Zacks Investment Research lowered Sientra from a “hold” rating to a “sell” rating in a report on Wednesday, May 17th. Lake Street Capital started coverage on Sientra in a report on Monday, April 17th. They issued a “buy” rating and a $11.00 target price for the company.

Sientra (SIEN) traded down 3.70% during mid-day trading on Thursday, reaching $9.36. 1,615,802 shares of the company were exchanged. Sientra has a 12 month low of $6.25 and a 12 month high of $10.37. The company’s market cap is $178.91 million. The stock’s 50-day moving average is $7.83 and its 200-day moving average is $8.42.

Sientra (NASDAQ:SIEN) last announced its quarterly earnings results on Tuesday, May 9th. The medical instruments supplier reported ($0.61) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.49) by $0.12. The firm had revenue of $7.50 million for the quarter, compared to analyst estimates of $5.98 million. Sientra had a negative net margin of 148.22% and a negative return on equity of 45.60%. The company’s revenue for the quarter was up 400.0% on a year-over-year basis. Equities analysts expect that Sientra will post ($2.31) earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Sientra, Inc. (SIEN) Upgraded by ValuEngine to “Hold”” was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://www.americanbankingnews.com/2017/06/24/sientra-inc-sien-upgraded-by-valuengine-to-hold.html.

A number of large investors have recently bought and sold shares of SIEN. Mission Wealth Management LLC bought a new stake in Sientra during the first quarter valued at $104,000. Wells Fargo & Company MN raised its stake in Sientra by 0.3% in the first quarter. Wells Fargo & Company MN now owns 12,871 shares of the medical instruments supplier’s stock valued at $108,000 after buying an additional 40 shares during the period. Highbridge Capital Management LLC bought a new stake in Sientra during the first quarter valued at $117,000. Dimensional Fund Advisors LP bought a new stake in Sientra during the first quarter valued at $127,000. Finally, Parametric Portfolio Associates LLC raised its stake in Sientra by 14.4% in the first quarter. Parametric Portfolio Associates LLC now owns 16,410 shares of the medical instruments supplier’s stock valued at $138,000 after buying an additional 2,065 shares during the period. Hedge funds and other institutional investors own 76.09% of the company’s stock.

About Sientra

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.